Leading policymakers, scientists, and experts from Asia’s health sector joined representatives from the World Bank at the 11th Asia-Pacific Future Trends Forum in Hanoi on November 12 to discuss global trends on health-related policies and to seek solutions to current challenges facing the sector.
Two influenza vaccines IVACFLU-S and IVACFLY, which were successfully produced in Vietnam, were introduced at a workshop held by the Institute of Vaccines and Medical Biologicals (IVAC) and the Programme for Appropriate Technology in Health (PATH) in the central province of Khanh Hoa on September 25.
The Institute of Vaccines and Medical Biologicals (IVAC) has completed the clinical trials of two types of seasonal influenza vaccine, which are expected to receive approval for commercial use in 2019, said Dr Le Van Be, head of the institute.